Document:

EX-10.1

 Exhibit 10.1 

This LIMITED WAIVER UNDER REVENUE INTEREST PURCHASE AGREEMENT (this “Waiver”) is made and entered into as of
August 14, 2022 (referred to herein as the “Effective Date”), by and among ATNX SPV, LLC, a Delaware limited liability corporation (“Seller”), Athenex, Inc., a Delaware corporation (“Parent”),
Oaktree-TCDRS Strategic Credit, LLC, a Delaware limited liability company (“Oaktree TCDRS”), Oaktree-Minn Strategic Credit, LLC, a Delaware limited liability company (“Oaktree Minn”), Oaktree-Forrest Multi-Strategy,
LLC, a Delaware limited liability company (“Oaktree Forrest”), Oaktree-TBMR Strategic Credit Fund C, LLC, a Delaware limited liability company (“Oaktree TBMR C”), Oaktree-TBMR Strategic Credit Fund F, LLC, a
Delaware limited liability company (“Oaktree TBMR F”), Oaktree-TBMR Strategic Credit Fund G, LLC, a Delaware limited liability company (“Oaktree TBMR G”), Oaktree-TSE 16 Strategic Credit, LLC, a Delaware limited
liability company (“Oaktree TSE”), INPRS Strategic Credit Holdings, LLC, a Delaware limited liability company (“Oaktree INPRS”), Oaktree Gilead Investment Fund AIF (Delaware), L.P., a Delaware limited liability
partnership (“Oaktree Gilead”), Oaktree Strategic Income II, Inc., a Delaware corporation (“Oaktree Strategic Income”), Oaktree Specialty Lending Corporation, a Delaware corporation (“Oaktree Specialty
Lending”), and Oaktree Huntington-GCF Investment Fund (Direct Lending AIF), L.P., a Delaware limited liability partnership (“Oaktree GCF”, and collectively with Oaktree TCDRS, Oaktree
Minn, Oaktree Forrest, Oaktree TBMR C, Oaktree TBMR F, Oaktree TBMR G, Oaktree TSE, Oaktree INPRS, Oaktree Gilead, Oaktree Strategic Income, and Oaktree Specialty Lending, “Oaktree”), Sagard Healthcare Royalty Partners, LP, a Cayman
Islands exempt limited partnership (“Sagard Cayman”), and Sagard Healthcare Partners Co-Invest DAC, a company incorporated in Ireland, (registered no. 714903), the registered office of which
is at 32 Molesworth Street, Dublin 2 Ireland (“Sagard Ireland”, and together with Sagard Cayman, “Sagard”, and together with Oaktree, and Sagard’s and Oaktree’s respective successors and permitted assigns,
collectively, the “Purchasers,” and each, a “Purchaser”). Seller, Parent, Oaktree, Sagard Cayman and Sagard Ireland are each referred to herein individually as a “Party” or “party” and
collectively as the “Parties”. Capitalized terms used but not otherwise defined herein have the meanings given to them in the RIPA (as defined below). 

WHEREAS, on June 21, 2022, the Parties entered into that certain Revenue Interest Purchase Agreement (the
“RIPA”); and 
 WHEREAS, Parent has requested that Purchasers waive any obligation of Parent to wire the
$7,500,000 in the Segregated Account to the Administrative Agent pursuant to the third sentence of Section 6.03(e) of the RIPA and any notice obligations under Section 6.03(e) of the RIPA. 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree, as
of the Effective Date, as follows: 
 1. Purchasers hereby waive (i) any notice obligations of Parent under Section 6.03(e) of the
RIPA and (ii) any obligations of Parent to wire the $7,500,000 in the Segregated Account to the Administrative Agent pursuant to the third sentence of Section 6.03(e) of the RIPA. Purchasers acknowledge and agree that notwithstanding
anything to the contrary in Section 6.03(e) of the RIPA, Parent is hereby free to transfer the funds from the Segregated Account to such other account as Parent may determine and otherwise use the funds as Parent may determine in its sole
discretion. 

 2. Except as specifically modified by this Waiver, the RIPA shall remain in full force and
effect and the execution and delivery of this Waiver shall not operate as a waiver of any other right, power or remedy of Purchasers nor constitute a waiver of any other provision of the RIPA. 

3. Sections 8.09 (Governing Law; Jurisdiction; Service of Process; Waiver of Jury Trial); 8.10 (Severability) and 8.11 (Counterparts;
Effectiveness) of the RIPA are incorporated by reference herein mutatis mutandis. 
 [Signature Pages Follow] 

 IN WITNESS WHEREOF, the Parties have caused this Waiver to be duly executed by their
respective authorized officers as of the date first above written. 
  

			
	ATNX SPV, LLC
		
	By:	 	/s/ Daniel Lang
	Name:	 	Daniel Lang, M.D.
	Title:	 	Board Member, Chief Executive Officer and Secretary

  

			
	ATHENEX, INC.
		
	By:	 	/s/ Johnson Y.N. Lau 
	Name:	 	Johnson Y.N. Lau
	Title:	 	Chairman and Chief Executive Officer

 
			
	 Oaktree-TCDRS Strategic Credit, LLC

Oaktree-Minn Strategic Credit, LLC
 Oaktree-Forrest
Multi-Strategy, LLC
 Oaktree-TBMR Strategic Credit Fund C, LLC

Oaktree-TBMR Strategic Credit Fund F, LLC
 Oaktree-TBMR
Strategic Credit Fund G, LLC
 Oaktree-TSE 16 Strategic Credit, LLC

INPRS Strategic Credit Holdings, LLC
  

By: Oaktree Capital Management, L.P.
 Its: Manager

		
	By:	 	/s/ Jessica Dombroff
	Name:	 	Jessica Dombroff
	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
	Name:	 	Maria Attaar
	Title:	 	Vice President
	
	 Oaktree Gilead Investment Fund AIF (Delaware), L.P.

 
 By: Oaktree Fund AIF Series, L.P. – Series T

Its: General Partner
  

By: Oaktree Fund GP AIF, LLC
 Its: Managing Member

 
 By: Oaktree Fund GP III, L.P.

Its: Managing Member

		
	By:	 	/s/ Jessica Dombroff
	Name:	 	Jessica Dombroff
	Title:	 	Authorized Signatory
		
	By:	 	/s/ Maria Attaar
	Name:	 	Maria Attaar
	Title:	 	Authorized Signatory

 
			
	 Oaktree Strategic Income II Inc.

Oaktree Specialty Lending Corporation
  

By: Oaktree Fund Advisors, LLC
 Its: Investment
Adviser

		
	By:	 	/s/ Jessica Dombroff
	Name:	 	Jessica Dombroff
	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
	Name:	 	Maria Attaar
	Title:	 	Vice President
	
	 Oaktree Huntington-GCF Investment Fund
(Direct Lending AIF), L.P.
  
 By: Oaktree
Huntington-GCF Investment Fund (Direct Lending AIF) GP, L.P.
 Its: General Partner

 
 By: Oaktree Huntington-GCF Investment Fund
(Direct Lending AIF) GP, LLC
 Its: General Partner
  

By: Oaktree Fund GP III, L.P.
 Its: Managing Member

		
	By:	 	/s/ Jessica Dombroff
	Name:	 	Jessica Dombroff
	Title:	 	Authorized Signatory
		
	By:	 	/s/ Maria Attaar
	Name:	 	Maria Attaar
	Title:	 	Authorized Signatory

 
			
	 SAGARD HEALTHCARE ROYALTY PARTNERS, LP
  

By: Sagard Healthcare Royalty Partners GP LLC, its general partner

		
	By:	 	/s/ Adam Vigna
	Name:	 	Adam Vigna
	Title:	 	Chief Investment Officer
		
	By:	 	/s/ Jason Sneah
	Name:	 	Jason Sneah
	Title:	 	Manager
	
	 SAGARD HEALTHCARE PARTNERS CO-INVEST
DAC

		
	By:	 	/s/ Kate Macken
	Name:	 	Kate Macken
	Title:	 	DirectorEX-10.2

 Exhibit 10.2 

SIXTH AMENDMENT TO CREDIT AND GUARANTY AGREEMENT 

THIS SIXTH AMENDMENT TO CREDIT AND GUARANTY AGREEMENT (this “Amendment”), dated as of August 14, 2022, is made by
and among ATHENEX, INC., a Delaware corporation (as applicable, the “Borrower”), the Lenders party hereto and OAKTREE FUND ADMINISTRATION, LLC, as administrative agent for the Lenders (in such capacity, the
“Administrative Agent”). 
 WHEREAS, the parties hereto are party to that certain Credit and Guaranty Agreement,
dated as of June 19, 2020 (as amended by that certain First Amendment and Limited Waiver to Credit and Guaranty Agreement, dated as of June 3, 2021, that certain Second Amendment to Credit and Guaranty Agreement, dated December 14,
2021, that certain Third Amendment to Credit and Guaranty Agreement and First Amendment to Warrants, dated as of January 19, 2022, that certain Fourth Amendment to Credit and Guaranty Agreement, Second Amendment to the Warrants and Partial
Release of Collateral, dated as of June 21, 2022, that certain Fifth Amendment to Credit and Guaranty Agreement, dated as of June 29, 2022, and as further amended, restated or modified from time to time, the “Credit
Agreement”) by and among the Borrower, the Guarantors party thereto from time to time, the Lenders party thereto from time to time, and the Administrative Agent; 

WHEREAS, Section 3.03(b)(iv)(B) of the Credit Agreement requires that the Borrower make a mandatory prepayment in the principal
amount equal to $7,500,000, plus accrued and unpaid interest in respect of the principal amount being prepaid, the Exit Fee in respect of the principal amount being prepaid and the Prepayment Fee in respect of the principal amount being prepaid (the
“Specified Prepayment”) under certain circumstances; and 
 WHEREAS, the Borrower has requested that the Lenders and
the Administrative Agent agree to (i) make certain amendments to the Credit Agreement and (ii) waive the requirement to make the Specified Prepayment, in each case, subject to the terms and conditions contained herein. 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto
agree as follows. 
 SECTION 1 Capitalized Terms. All capitalized terms used in this Amendment (including in the recitals hereof) and not
otherwise defined herein shall have the meanings assigned to them in the Credit Agreement. 
 SECTION 2 Amendment to the Credit Agreement.
Notwithstanding anything in the Credit Agreement or the other Loan Documents to the contrary, the Lenders and the Borrower hereby agree that on the Sixth Amendment Effective Date, Section 3.03(b)(iv)(B) is hereby amended and restated in its
entirety to read as follows: 
 “(B) On or prior to September 30, 2022, the Borrower shall make a mandatory prepayment in a
principal amount equal to the amount by which $6,875,000 exceeds any prepayments made by the Borrower on or prior to such date pursuant to Section 3.03(b)(i) from the Net Cash Proceeds from the sale of the China API business to TiHe Capital
(Beijing) Co., Ltd. in accordance with the Equity Purchase Agreement, dated as of July 7, 2022 (the “China API Sale”), plus accrued and unpaid interest in respect of the principal amount being repaid, the Exit Fee in respect of
the principal amount being repaid and the Prepayment Fee in respect of the principal amount being repaid. The principal amount of such prepayment shall reduce
dollar-for-dollar the amount of any mandatory prepayment that would be required pursuant to Section 3.03(b)(i) from the Net Cash Proceeds of the China API Sale
after September 30, 2022. By way of example, if the Borrower consummates the China API Sale prior to September 30, 2022 and makes a mandatory prepayment of the Loans pursuant to Section 3.03(b)(i) on or prior to such date in excess of
$6,875,000, then no further mandatory prepayment shall be required pursuant to this Section 3.03(b)(iv)(B).” 
 SECTION 3 Limited
Waiver. Subject to the satisfaction of the conditions precedent specified in Section 4 hereof, the Administrative Agent and the Lenders hereby waive any Default or Event of Default under Section 11.01(a) and Section 11.01(b) of
the Credit Agreement arising out of the failure to make the Specified Prepayment (the “Payment Defaults”) and any Default or Event of Default under Section 11.01(d) of the Credit Agreement arising out of the failure to provide
timely notice of the Payment Defaults pursuant to Section 8.02(a) of the Credit Agreement (together with the Payment Defaults, the “Specified Defaults”). For the avoidance of doubt, the Borrower shall be

  
 1 

 
required to make the mandatory prepayment required pursuant to Section 3.03(b)(iv)(B) of the Credit Agreement as amended by this Amendment on the date set forth therein. 

SECTION 4 Effectiveness. Sections 2 and 3 to this Amendment shall become effective only upon the satisfaction or waiver by the Lenders of the
following conditions precedent (the date of such satisfaction or waiver of the following conditions being referred herein as the “Sixth Amendment Effective Date”): 

(a) Each of the Borrower and the Lenders shall have executed this Amendment and the Administrative Agent shall have received a fully executed
copy of this Amendment. 
 (b) The representations and warranties of the Borrower set out in Section 5 below shall be true and correct
on and as of the Sixth Amendment Effective Date, except for any representation or warranty expressly stated to be made as of a specific date, in which case such representation or warranty shall be true and correct as of such specific date. 

SECTION 5 Representations and Warranties. 

The Borrower represents and warrants as of the date hereof and on the Sixth Amendment Effective Date that: 

(a) Power and Authority. The Borrower has full power, authority and legal right to enter into and perform its obligations under this
Amendment and the other Loan Documents to which it is a party. 
 (b) Authorization; Enforceability. The execution of this Amendment
and performance hereunder are within the Borrower’s corporate or other organizational powers and have been duly authorized by all necessary corporate or other organizational action including, if required, approval by all necessary holders of
Equity Interests. This Amendment has been duly executed and delivered by the Borrower and constitutes a legal, valid and binding obligation of the Borrower, enforceable against the Borrower in accordance with its terms, except as such enforceability
may be limited by (i) bankruptcy, insolvency, reorganization, moratorium or similar laws of general applicability affecting the enforcement of creditors’ rights and (ii) the application of general principles of equity (regardless of
whether such enforceability is considered in a proceeding in equity or at law). 
 (c) Governmental and Other Approvals; No
Conflicts. None of the execution, delivery and performance by the Borrower of the Amendment (i) requires any Governmental Approval of, registration or filing with, or any other action by, any Governmental Authority or any other Person,
except for such as have been obtained or made and are in full force and effect, (ii) will violate (1) any Law, (2) any Organic Document of the Borrower or (3) any order of any Governmental Authority, that in the case of
clause (ii)(1) or clause (ii)(3), individually or in the aggregate, could reasonably be expected to result in a Material Adverse Effect, (iii) will violate or result in a default under any Material Agreement
binding upon the Borrower that, individually or in the aggregate, could reasonably be expected to result in a Material Adverse Effect or (iv) will result in the creation or imposition of any Lien (other than Permitted Liens) on any asset of any
Obligor or any of its Subsidiaries. 
 (d) No Default or Event of Default. No event has occurred and is continuing or would result
after giving effect to this Amendment that would constitute an Event of Default or a Default (other than the Specified Defaults). 
 SECTION 6
Miscellaneous. 
 (a) References Within Loan Documents. Each reference in the Credit Agreement on and after the Sixth Amendment
Effective Date to “this Agreement” and the words “hereof,” “herein,” “hereunder,” or words of like import, shall mean and be a reference to the Credit Agreement as amended by Section 2 of this Amendment,.

 (b) Binding Effect. This Amendment binds and is for the benefit of the successors and permitted assigns of each party. 

  
 2 

 (c) Limited Waiver. Except as specifically modified above, (i) the Credit
Agreement and all other Loan Documents shall remain in full force and effect, and are hereby ratified and confirmed and (ii) the execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy
of the Administrative Agent or the Lenders nor constitute a waiver of any provision of the Credit Agreement or any of the Loan Documents. None of the Administrative Agent or any Lender is under any obligation to enter into this Amendment. The
entering into this Amendment by such parties shall not be deemed to limit or hinder any rights of any such party under the Loan Documents, nor, except as provided in Section 2, as applicable, shall it be deemed to create or infer a course of
dealing between any such party, on the one hand, and the Borrower, on the other hand, with regard to any provision of the Loan Documents. 

(d) Governing Law. THIS AMENDMENT SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK. 

(e) Severability of Provisions. Each provision of this Amendment is severable from every other provision in determining the
enforceability of any provision. 
 (f) Counterparts. This Amendment may be executed in any number of counterparts and by different
parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Amendment. Delivery of an executed counterpart of a signature page of this Amendment by facsimile, portable document
format (.pdf) or other electronic transmission will be as effective as delivery of a manually executed counterpart hereof. 
 (g) Loan
Documents. This Amendment and the documents related thereto shall constitute Loan Documents. 
 (h) Electronic Execution of Certain
Other Documents. The words “execution,” “execute”, “signed,” “signature,” and words of like import in or related to any document to be signed in connection with this Amendment and the transactions
contemplated hereby (including without limitation assignments, assumptions, amendments, waivers and consents) shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic
platforms approved by the Administrative Agent, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping
system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar
state laws based on the Uniform Electronic Transactions Act. 
 [Balance of Page Intentionally Left Blank; Signature Pages Follow]

  
 3 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Amendment, as of the date
first above written. 
 BORROWER AND ISSUER: 

			
	 ATHENEX, INC.,
 a Delaware
corporation

		
	By:	 	/s/ Johnson Y.N. Lau
	Name:	 	Dr. Johnson Y.N. Lau 
	Title:	 	Chairman and Chief Executive Officer

 
					
	 ADMINISTRATIVE AGENT:

	
	 OAKTREE FUND ADMINISTRATION, LLC

		
	By:	 	Oaktree Capital Management, L.P.
	Its:	 	Managing Member
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

  

					
	 LENDERS AND WARRANT HOLDERS:

	
	 OAKTREE-TCDRS STRATEGIC CREDIT, LLC

		
	By:	 	Oaktree Capital Management, L.P.
	Its:	 	Manager
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

  

					
	 EXELON STRATEGIC CREDIT HOLDINGS, LLC

		
	By:	 	Oaktree Capital Management, L.P.
	Its:	 	Manager
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

 
					
	 OAKTREE-NGP STRATEGIC CREDIT,
LLC

		
	By:	 	Oaktree Capital Management, L.P.
	Its:	 	Manager
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

  

					
	 OAKTREE-MINN STRATEGIC CREDIT LLC

		
	By:	 	Oaktree Capital Management, L.P.
	Its:	 	Manager
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

  

					
	 OAKTREE-FORREST MULTI-STRATEGY LLC

		
	By:	 	Oaktree Capital Management, L.P.
	Its:	 	Manager
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

 
			
	 OAKTREE-TBMR STRATEGIC CREDIT FUND C, LLC

		
	By:	 	Oaktree Capital Management, L.P.
	Its:	 	Manager
		
	By:	 	/s/ Jessica Dombroff
	Name:	 	Jessica Dombroff
	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
	Name:	 	Maria Attaar
	Title:	 	Vice President

  

					
	 OAKTREE-TBMR STRATEGIC CREDIT FUND F, LLC

		
	By:	 	Oaktree Capital Management, L.P.
	Its:	 	Manager
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

  

					
	 OAKTREE-TBMR STRATEGIC CREDIT FUND G, LLC

		
	By:	 	Oaktree Capital Management, L.P.
	Its:	 	Manager
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

 
					
	 OAKTREE-TSE 16 STRATEGIC CREDIT,
LLC

		
	By:	 	Oaktree Capital Management, L.P.
	Its:	 	Manager
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

  

					
	 INPRS STRATEGIC CREDIT HOLDINGS, LLC

		
	By:	 	Oaktree Capital Management, L.P.
	Its:	 	Manager
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	 Title:
	 	 Vice President

  

					
	 OAKTREE HUNTINGTON-GCF INVESTMENT FUND,
L.P.

		
	By:	 	Oaktree Huntington-GCF Investment Fund GP, L.P.
	Its:	 	General Partner
		
	By:	 	Oaktree Huntingon-GCF Investment Fund GP, LLC
	Its:	 	General Partner
		
	By:	 	Oaktree Fund GP I, L.P.
	Its:	 	Managing Member
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Authorized Signatory
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Authorized Signatory

 
					
	OAKTREE STRATEGIC INCOME II, INC.
		
	By:	 	Oaktree Fund Advisors, LLC
	Its:	 	Investment Advisor
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

  

					
	OAKTREE SPECIALTY LENDING CORPORATION
		
	By:	 	Oaktree Fund Advisors, LLC
	Its:	 	Investment Adviser
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

  

					
	OAKTREE STRATEGIC INCOME CORPORATION
		
	By:	 	Oaktree Fund Advisors, LLC
	Its:	 	Investment Adviser
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Vice President
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Vice President

 
					
	OAKTREE GILEAD INVESTMENT FUND, L.P.
		
	By:	 	Oaktree Gilead Investment Fund GP, L.P.
	Its:	 	General Partner
		
	By:	 	Oaktree Fund GP, LLC
	Its:	 	General Partner
		
	By:	 	Oaktree Fund GP I, L.P.
	Its:	 	Managing Member
		
	By:	 	/s/ Jessica Dombroff
		 	Name:	 	Jessica Dombroff
		 	Title:	 	Authorized Signatory
		
	By:	 	/s/ Maria Attaar
		 	Name:	 	Maria Attaar
		 	Title:	 	Authorized Signatory

  

			
	 SAGARD HEALTHCARE ROYALTY PARTNERS, LP, acting through its general partner, SAGARD
HEALTHCARE ROYALTY PARTNERS GP LLC

		
	 By:
	 	 /s/ Adam Vigna

		 	 Name: Adam Vigna

		 	 Title: Chief Investment Officer

		
	 By:
	 	 /s/ Jason Sneah

		 	 Name: Jason Sneah

		 	 Title: Manager

	
	OPB SHRP CO-INVEST CREDIT LIMITED
		
	 By:
	 	 /s/ Jennifer Hartviksen

		 	 Name: Jennifer Hartviksen

		 	 Title: Managing Director, Global Credit

	
	SIMCOE SHRP CO-INVEST CREDIT LTD.
		
	By:	 	/s/ Jennifer Hartviksen
		 	Name: Jennifer Hartviksen 

		 	Title: Managing Director, Global Credit

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]